5:31 am AVEO Pharma and Astellas (ALPMY) to end worldwide collaboration & license agreement for development and commercialization of Tivozanib; Phase 2 Colorectal Cancer Study discontinued – HedgeChatter

5:31 am AVEO Pharma and Astellas (ALPMY) to end worldwide collaboration & license agreement for development and commercialization of Tivozanib; Phase 2 Colorectal Cancer Study discontinued

15 Feb

5:31 am AVEO Pharma and Astellas (ALPMY) to end worldwide collaboration & license agreement for development and commercialization of Tivozanib; Phase 2 Colorectal Cancer Study discontinued

Bystocknews AVEO, stock Comments Off

View todays social media effects on AVEO

View the latest stocks trending across Twitter. Click to view dashboard

See who AVEO is hiring next, click here to view

Author